Basic Information
| RNALocate ID: | RLID:11003529 |
| RNA Symbol: | hsa-miR-766-3p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-766 |
| RNA ID: | miRBase:MIMAT0003888 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002544 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003527 | Exosome | Plasma | 23663360 |
| RLID:11003528 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID-D:11000562 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001437 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-766-3p | Medulloblastoma | MNDR-E-MI-69061 |
| MNDR | hsa-miR-766-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-69062 |
| MNDR | hsa-miR-766-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-69063 |
| MNDR | hsa-miR-766-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-69064 |
| MNDR | hsa-miR-766-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-69065 |
| MNDR | hsa-miR-766-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-69066 |
| MNDR | hsa-miR-766-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-69067 |
| MNDR | hsa-miR-766-3p | Her2-receptor positive breast cancer | MNDR-E-MI-69068 |
| MNDR | hsa-miR-766-3p | Prostate cancer | MNDR-E-MI-69069 |
| MNDR | hsa-miR-766-3p | Gastric cancer | MNDR-E-MI-69070 |
| MNDR | hsa-miR-766-3p | Alzheimer disease | MNDR-E-MI-69071 |
| MNDR | hsa-miR-766-3p | Polycystic ovary syndrome | MNDR-E-MI-69072 |
| MNDR | hsa-miR-766-3p | Head and neck cancer | MNDR-E-MI-69073 |
| MNDR | hsa-miR-766-3p | Leukemia | MNDR-E-MI-69074 |
| MNDR | hsa-miR-766-3p | Cardiovascular disease | MNDR-E-MI-69075 |
| MNDR | hsa-miR-766-3p | Lung cancer | MNDR-E-MI-69076 |
| MNDR | hsa-miR-766-3p | Parkinson disease | MNDR-E-MI-69077 |
| MNDR | hsa-miR-766-3p | Breast cancer | MNDR-E-MI-69078 |
| MNDR | hsa-miR-766-3p | Pancreatic cancer | MNDR-E-MI-69079 |
| MNDR | hsa-miR-766-3p | Melanoma | MNDR-E-MI-69080 |
| MNDR | hsa-miR-766-3p | Rectum adenocarcinoma | MNDR-E-MI-69081 |
| MNDR | hsa-miR-766-3p | Nephroblastoma | MNDR-E-MI-69082 |
| MNDR | hsa-miR-766-3p | Colon cancer | MNDR-E-MI-69083 |
| MNDR | hsa-miR-766-3p | Colon adenocarcinoma | MNDR-E-MI-69084 |
| MNDR | hsa-miR-766-3p | Ovarian cancer | MNDR-E-MI-69085 |
| MNDR | hsa-miR-766-3p | Prostate adenocarcinoma | MNDR-E-MI-69086 |
| MNDR | hsa-miR-766-3p | Carcinoma ductal breast | MNDR-E-MI-69087 |
| MNDR | hsa-miR-766-3p | Glioma | MNDR-E-MI-69088 |
| MNDR | hsa-miR-766-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-69089 |
| MNDR | hsa-miR-766-3p | Osteosarcoma | MNDR-E-MI-69090 |
| MNDR | hsa-miR-766-3p | Gastric adenocarcinoma | MNDR-E-MI-69091 |
| MNDR | hsa-miR-766-3p | Lung squamous cell carcinoma | MNDR-E-MI-69092 |
| MNDR | hsa-miR-766-3p | Adrenocortical cancer | MNDR-E-MI-69093 |
| MNDR | hsa-miR-766-3p | Ovarian carcinoma | MNDR-E-MI-69094 |
| MNDR | hsa-miR-766-3p | Bladder urothelial carcinoma | MNDR-E-MI-69095 |
| MNDR | hsa-miR-766-3p | Pancreatic adenocarcinoma | MNDR-E-MI-69096 |
| MNDR | hsa-miR-766-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-69097 |
| MNDR | hsa-miR-766-3p | Carcinoma renal cell | MNDR-E-MI-69098 |
| MNDR | hsa-miR-766-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-69099 |
| MNDR | hsa-miR-766-3p | Renal clear cell carcinoma | MNDR-E-MI-69100 |
| MNDR | hsa-miR-766-3p | Large cell carcinoma | MNDR-E-MI-69101 |
| MNDR | hsa-miR-766-3p | Cholangiocarcinoma | MNDR-E-MI-69102 |
| MNDR | hsa-miR-766-3p | Esophageal cancer | MNDR-E-MI-69103 |
| MNDR | hsa-miR-766-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-69104 |
| MNDR | hsa-miR-766-3p | T acute lymphoblastic leukemia | MNDR-E-MI-69105 |
| MNDR | hsa-miR-766-3p | Acute t cell leukemia | MNDR-E-MI-69106 |
| MNDR | hsa-miR-766-3p | Breast invasive carcinoma | MNDR-E-MI-69107 |
| MNDR | hsa-miR-766-3p | Hepatocellular carcinoma | MNDR-E-MI-69108 |
| MNDR | hsa-miR-766-3p | Malignant pleural mesothelioma | MNDR-E-MI-69109 |
| MNDR | hsa-miR-766-3p | Retinoblastoma | MNDR-E-MI-69110 |
| MNDR | hsa-miR-766-3p | Barrett's adenocarcinoma | MNDR-E-MI-69111 |
| MNDR | hsa-miR-766-3p | Neuromyelitis optica | MNDR-E-MI-69112 |
| MNDR | hsa-miR-766-3p | Skin cutaneous melanoma | MNDR-E-MI-69113 |
| MNDR | hsa-miR-766-3p | Skin melanoma | MNDR-E-MI-69114 |
| MNDR | hsa-miR-766-3p | Colorectal cancer | MNDR-E-MI-69115 |
| MNDR | hsa-miR-766-3p | Nasopharynx carcinoma | MNDR-E-MI-69116 |
| MNDR | hsa-miR-766-3p | Nasopharyngeal cancer | MNDR-E-MI-69117 |
| MNDR | hsa-miR-766-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-69118 |
| MNDR | hsa-miR-766-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-69119 |
| MNDR | hsa-miR-766-3p | Barrett's carcinogenesis | MNDR-E-MI-69120 |
| MNDR | hsa-miR-766-3p | Breast cancer her3+ negative | MNDR-E-MI-69121 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCG1 | Homo sapiens | RR00024647 |
TOP